CDK1 dependent phosphorylation of hTERT contributes to cancer progression

Mami Yasukawa(National Cancer Centre Japan), Kenkichi Masutomi(National Cancer Centre Japan)
bioRxiv (Cold Spring Harbor Laboratory)
February 21, 2019
10.1101/556514
Cited by 6

Related Papers

CDK1 dependent phosphorylation of hTERT contributes to cancer progression
|Nature Communications|2020|63
Association of longer telomere length in cancer cells and cancer-associated fibroblasts with worse prognosis
|JNCI Journal of the National Cancer Institute|2022|18
Phosphorylation of <scp>hTERT</scp> at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organs
|The Journal of Pathology|2022|13